THAMAN MICHAEL H 4
4 · UL Solutions Inc. · Filed Jun 10, 2026
Research Summary
AI-generated summary of this filing
UL Solutions (ULS) Director Michael Thaman Receives 3-Share Award
What Happened Michael H. Thaman, a director of UL Solutions Inc. (ULS), was granted 3 deferred restricted stock units (DRSUs) on June 8, 2026. The units were recorded as acquired at $0.00 (derivative award). These DRSUs represent contingent rights to receive shares in the future rather than immediate share ownership.
Key Details
- Transaction date and type: 2026-06-08 — Grant/award of 3 DRSUs (transaction code A); reported on Form 4 filed 2026-06-10.
- Price: $0.00 per unit (compensatory award).
- Shares owned after transaction: Not specified in the provided filing summary.
- Vesting/settlement: DRSUs vest on the earlier of May 20, 2027 or the date of the annual meeting following the May 20, 2026 grant; settlement will be in Class A common stock per the company plan.
- Dividend equivalents: Dividend equivalent rights accrue on the DRSUs and vest proportionately with them.
- Timeliness: Filing appears timely (transaction 6/8/2026; Form 4 filed 6/10/2026).
Context DRSUs are a deferred, compensatory award that convert to shares upon vesting and/or settlement; they are not an open-market purchase or sale and thus do not reflect an immediate change in economic exposure. Dividend equivalents that have accrued on the units will also be settled in shares and vest alongside the underlying DRSUs.
Insider Transaction Report
- Award
Deferred Restricted Stock Units
[F1][F2][F3][F4]2026-06-08+3→ 2,209 total→ Class A Common Stock (3 underlying)
Footnotes (4)
- [F1]Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
- [F2]Represents accrual of dividend equivalent rights on DRSUs held by the Reporting Person.
- [F3]The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vest on the earlier of May 20, 2027, or the date of the annual meeting following the May 20, 2026, grant date and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Plan, or (ii) as otherwise provided by the Plan.
- [F4]Includes DRSUs and all dividend equivalent rights that have accrued on such DRSUs to date.